Ranbaxy Recalls Atorvastatin Calcium Tablets Due to Foreign Tablet Presence
Ranbaxy Inc. is recalling 32,208 bottles of Atorvastatin Calcium 10 mg tablets because a 20 mg tablet was found inside a sealed 10 mg bottle.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II. Per the rubric, FDA Class II recalls are assigned a severity score of 4 (Severe), particularly when involving potential dosage errors that could lead to adverse health consequences.
Plain-English summary
Ranbaxy Inc. is recalling 32,208 bottles of Atorvastatin Calcium Tablets, 10 mg, 90-count. The recall was initiated after a pharmacist reported finding an Atorvastatin 20 mg tablet inside a sealed bottle of 10 mg tablets. The affected product is identified by Lot # 2407258 and an expiration date of 05/14.
The product was distributed nationwide. The FDA has classified this recall as Class II, indicating a situation in which use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers should check their medication for the specific lot number and expiration date listed above. If the product matches the recalled description, they should stop using it and contact their pharmacist or healthcare provider for guidance on obtaining a replacement.
The recalled product
- Product
- ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)
- Brand
- ATORVASTATIN CALCIUM
- Manufacturer
- Ranbaxy Inc.
- Category
- Drug — Prescription Medication
- Affected units
- 32,208
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2407258
- Exp 05/14
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ATORVASTATIN CALCIUM
- ModerateAtorvastatin 40 mg tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin 80 mg tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin 10 mg tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin 20 mg tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-22
- HighBiocon Pharma atorvastatin calcium tablets recalled for failed dissolution specifications
FDA (Drugs) · 2025-04-09
Same manufacturer · Ranbaxy Inc.
See all →- ModerateRanbaxy Recalls Absorica LD Isotretinoin Capsules Due to Undeclared Dye
FDA (Drugs) · 2015-08-12
- ModerateRanbaxy Recalls Atorvastatin Calcium Tablets Due to Foreign Tablet Presence
FDA (Drugs) · 2014-03-05
- LowRanbaxy Recalls Lac-Hydrin Lotion Due to Crystallization Texture
FDA (Drugs) · 2013-02-20
- LowRanbaxy Recalls Lac-Hydrin Cream Due to Crystallization
FDA (Drugs) · 2013-02-20
- SevereRanbaxy Recalls Atorvastatin Calcium Tablets Due to Glass Particulates
FDA (Drugs) · 2012-12-05
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02